Lansforsakringar Fondforvaltning’s Halozyme HALO Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,268	Closed	-$1.09M	–	570
2025 Q4	$1.09M	Buy	16,268 +7,292	+81%	+$491K	0.01%	514
2025 Q3	$658K	Sell	8,976 -5,802	-39%	-$385K	﹤0.01%	513
2025 Q2	$769K	Buy	14,778 +5,321	+56%	+$303K	﹤0.01%	512
2025 Q1	$603K	Buy	9,457 +550	+6%	+$31.9K	﹤0.01%	533
2024 Q4	$426K	Buy	+8,907	New	+$457K	﹤0.01%	534

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lansforsakringar Fondforvaltning's HALO Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning sold out of Halozyme (HALO) in Q1 2026, closing a stake of 16,268 shares — an estimated $1.09M sold.

Lansforsakringar Fondforvaltning first reported a position in HALO in Q4 2024 and held it in 5 quarters. The position peaked at $1.09M in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Lansforsakringar Fondforvaltning reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
Lansforsakringar Fondforvaltning sold 16,268 Halozyme shares in Q1 2026, an estimated $1.09M.
Lansforsakringar Fondforvaltning first reported a position in Halozyme in Q4 2024 and held it in 5 quarters.
Lansforsakringar Fondforvaltning's Halozyme position peaked at $1.09M in Q4 2025.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.